Iterum Therapeutics plc
(NASDAQ: ITRM)

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

0.322 -

-0.021 (-6.12%)
Range 0.322 - 0.349   (8.39%)
Open 0.333
Previous Close 0.343
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 301,339
Value 65,930
Remark -
Delayed prices. Updated at 29 Jan 2026 09:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis